PFE Relative Valuation
PFE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PFE is overvalued; if below, it's undervalued.
Historical Valuation
Pfizer Inc (PFE) is now in the Fair zone, suggesting that its current forward PE ratio of 8.57 is considered Fairly compared with the five-year average of 12.28. The fair price of Pfizer Inc (PFE) is between 21.37 to 51.53 according to relative valuation methord.
Relative Value
Fair Zone
21.37-51.53
Current Price：25.57
Fair
8.61
PE
1Y
3Y
5Y
Trailing
Forward
7.50
EV/EBITDA
Pfizer Inc. (PFE) has a current EV/EBITDA of 7.50. The 5-year average EV/EBITDA is 9.48. The thresholds are as follows: Strongly Undervalued below 2.52, Undervalued between 2.52 and 6.00, Fairly Valued between 12.96 and 6.00, Overvalued between 12.96 and 16.44, and Strongly Overvalued above 16.44. The current Forward EV/EBITDA of 7.50 falls within the Historic Trend Line -Fairly Valued range.
9.18
EV/EBIT
Pfizer Inc. (PFE) has a current EV/EBIT of 9.18. The 5-year average EV/EBIT is 12.24. The thresholds are as follows: Strongly Undervalued below 1.13, Undervalued between 1.13 and 6.69, Fairly Valued between 17.80 and 6.69, Overvalued between 17.80 and 23.35, and Strongly Overvalued above 23.35. The current Forward EV/EBIT of 9.18 falls within the Historic Trend Line -Fairly Valued range.
2.34
PS
Pfizer Inc. (PFE) has a current PS of 2.34. The 5-year average PS is 2.88. The thresholds are as follows: Strongly Undervalued below 1.81, Undervalued between 1.81 and 2.34, Fairly Valued between 3.42 and 2.34, Overvalued between 3.42 and 3.95, and Strongly Overvalued above 3.95. The current Forward PS of 2.34 falls within the Undervalued range.
7.51
P/OCF
Pfizer Inc. (PFE) has a current P/OCF of 7.51. The 5-year average P/OCF is 9.06. The thresholds are as follows: Strongly Undervalued below 4.41, Undervalued between 4.41 and 6.73, Fairly Valued between 11.39 and 6.73, Overvalued between 11.39 and 13.72, and Strongly Overvalued above 13.72. The current Forward P/OCF of 7.51 falls within the Historic Trend Line -Fairly Valued range.
7.65
P/FCF
Pfizer Inc. (PFE) has a current P/FCF of 7.65. The 5-year average P/FCF is 11.43. The thresholds are as follows: Strongly Undervalued below 3.27, Undervalued between 3.27 and 7.35, Fairly Valued between 15.51 and 7.35, Overvalued between 15.51 and 19.59, and Strongly Overvalued above 19.59. The current Forward P/FCF of 7.65 falls within the Historic Trend Line -Fairly Valued range.
Pfizer Inc (PFE) has a current Price-to-Book (P/B) ratio of 1.57. Compared to its 3-year average P/B ratio of 1.85 , the current P/B ratio is approximately -15.41% higher. Relative to its 5-year average P/B ratio of 2.46, the current P/B ratio is about -36.24% higher. Pfizer Inc (PFE) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 6.01%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 7.18% , the current FCF yield is about -100.00% lower.
1.57
P/B
Median3y
1.85
Median5y
2.46
7.14
FCF Yield
Median3y
6.01
Median5y
7.18
Competitors Valuation Multiple
The average P/S ratio for PFE's competitors is 3.88, providing a benchmark for relative valuation. Pfizer Inc Corp (PFE) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -5.92%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PFE decreased by 1.53% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 12.43 to 14.94.
The secondary factor is the Revenue Growth, contributed -5.92%to the performance.
Overall, the performance of PFE in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Pfizer Inc (PFE) currently overvalued or undervalued?
What is Pfizer Inc (PFE) fair value?
How does PFE's valuation metrics compare to the industry average?
What is the current P/B ratio for Pfizer Inc (PFE) as of Dec 05 2025?
What is the current FCF Yield for Pfizer Inc (PFE) as of Dec 05 2025?
What is the current Forward P/E ratio for Pfizer Inc (PFE) as of Dec 05 2025?